Results overview: Found 27 records in 0.02 seconds.
Articles, 18 records found
Research literature, 9 records found
Articles 18 records found  1 - 10next  jump to record:
1.
15 p, 2.8 MB Association of candidate genetic variants and circulating levels of ApoE/ApoJ with common neuroimaging features of cerebral amyloid angiopathy / Bonaterra-Pastra, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Benitez, Sonia (Institut d'Investigació Biomèdica Sant Pau) ; Pancorbo, Olalla (Hospital Universitari Vall d'Hebron) ; Rodriguez-Luna, David (Hospital Universitari Vall d'Hebron) ; Vert, Carla (Hospital Universitari Vall d'Hebron) ; Rovira, Alex (Hospital Universitari Vall d'Hebron) ; Freijo, M. Mar (Instituto de Investigación Sanitaria Biocruces Bizkaia) ; Tur, Silvia (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Martínez-Zabaleta, Maite (Hospital de Donostia (Sant Sebastià, País Basc)) ; Cardona, Pere-Joan (Hospital Universitari de Bellvitge) ; Vera, Rocío (Hospital Universitario Ramón y Cajal (Madrid)) ; Lebrato-Hernández, Lucia (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Arenillas, Juan F. (Universidad de Valladolid) ; Pérez-Sánchez, Soledad (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ; Domínguez-Mayoral, Ana (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ; Martí-Fàbregas, Joan (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Mauri, Gerard (Hospital Universitari Arnau de Vilanova) ; Montaner, Joan (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ; Sanchez-Quesada, Jose Luis (Institut d'Investigació Biomèdica Sant Pau) ; Hernandez Guillamon, Maria Mar (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Cerebral amyloid angiopathy (CAA) is characterized by the accumulation of amyloid-β (Aβ) in brain vessels and is a main cause of lobar intracerebral hemorrhage (ICH) in the elderly. CAA is associated with magnetic resonance imaging (MRI) markers of small vessel disease (SVD). [...]
2023 - 10.3389/fnagi.2023.1134399
Frontiers in aging neuroscience, Vol. 15 (april 2023)  
2.
10 p, 2.3 MB New candidate blood biomarkers potentially associated with white matter hyperintensities progression / Jiménez-Balado, Joan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Pizarro Gonzálvez, Jesús (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Riba-Llena, Iolanda (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Penalba, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Faura, Júlia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Palà, Elena (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Montaner, Joan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Hernández-Guillamon, Mar (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Delgado Martínez, María Pilar (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
We aimed to discover blood biomarkers associated with longitudinal changes in white matter hyperintensities (WMH). This study was divided into a discovery phase and a replication phase. Subjects in both studies were patients with hypertension, aged 50-70, who underwent two magnetic resonance imaging (MRI) sessions and blood extractions over a 4-year follow-up period. [...]
2021 - 10.1038/s41598-021-93498-w
Scientific reports, Vol. 11 (july 2021)  
3.
22 p, 3.2 MB Survival Bias and Crosstalk between Chronological and Behavioral Age : Age- and Genotype-Sensitivity Tests Define Behavioral Signatures in Middle-Aged, Old, and Long-Lived Mice with Normal and AD-Associated Aging / Gimenez-Llort, Lydia (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ; Marín-Pardo, Daniela (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ; Marazuela, Paula (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Hernandez Guillamon, Maria Mar (Hospital Universitari Vall d'Hebron. Institut de Recerca)
New evidence refers to a high degree of heterogeneity in normal but also Alzheimer's disease (AD) clinical and temporal patterns, increased mortality, and the need to find specific end-of-life prognosticators. [...]
2021 - 10.3390/biomedicines9060636
Biomedicines, Vol. 9 (june 2021)  
4.
30 p, 1.3 MB SSAO/VAP-1 in Cerebrovascular Disorders : A Potential Therapeutic Target for Stroke and Alzheimer's Disease / Unzeta López, Mercedes (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Hernandez Guillamon, Maria Mar (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Sun, Ping (University of Pittsburgh School of Medicine) ; Solé Piñol, Montserrat (Hospital Universitari Vall d'Hebron. Institut de Recerca)
The semicarbazide-sensitive amine oxidase (SSAO), also known as vascular adhesion protein-1 (VAP-1) or primary amine oxidase (PrAO), is a deaminating enzyme highly expressed in vessels that generates harmful products as a result of its enzymatic activity. [...]
2021 - 10.3390/ijms22073365
International journal of molecular sciences, Vol. 22 (march 2021)  
5.
15 p, 1.0 MB Circulating AQP4 Levels in Patients with Cerebral Amyloid Angiopathy-Associated Intracerebral Hemorrhage / Marazuela, Paula (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Bonaterra-Pastra, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Faura, Júlia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Penalba, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Pizarro Gonzálvez, Jesús (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Pancorbo, Olalla (Hospital Universitari Vall d'Hebron) ; Rodríguez-Luna, David (Hospital Universitari Vall d'Hebron) ; Vert, Carla (Hospital Universitari Vall d'Hebron) ; Rovira, Alex (Hospital Universitari Vall d'Hebron) ; Pujadas, Francesc (Hospital Universitari Vall d'Hebron) ; Freijo, M. Mar (Instituto de Investigación Sanitaria Biocruces Bizkaia) ; Tur, Silvia (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Martínez-Zabaleta, Maite (Hospital Universitario de Donostia (Sant Sebastià, País Basc)) ; Cardona, Pere-Joan (Hospital Universitari de Bellvitge) ; Vera, Rocío (Hospital Universitario Ramón y Cajal (Madrid)) ; Lebrato-Hernández, Lucia (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Arenillas, Juan F.. (Universidad de Valladolid) ; Pérez-Sánchez, Soledad (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ; Montaner, Joan (Universidad de Sevilla) ; Delgado Martínez, María Pilar (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Hernandez Guillamon, Maria Mar (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Cerebral amyloid angiopathy (CAA) is a major cause of lobar intracerebral hemorrhage (ICH) in elderly patients. Growing evidence suggests a potential role of aquaporin 4 (AQP4) in amyloid-beta-associated diseases, including CAA pathology. [...]
2021 - 10.3390/jcm10050989
Journal of clinical medicine, Vol. 10 (march 2021)  
6.
10 p, 3.9 MB Factors Secreted by Endothelial Progenitor Cells Enhance Neurorepair Responses after Cerebral Ischemia in Mice / Rosell Novel, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Morancho, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Navarro Sobrino, Míriam (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martinez-Saez, Elena (Hospital Universitari Vall d'Hebron) ; Hernandez Guillamon, Maria Mar (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Lope-Piedrafita, Silvia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Barceló, Verónica (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Borràs i Serres, Francesc Enric (Hospital Universitari Vall d'Hebron) ; Penalba, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; García Bonilla, Lídia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Montaner, Joan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Cell therapy with endothelial progenitor cells (EPCs) has emerged as a promising strategy to regenerate the brain after stroke. Here, we aimed to investigate if treatment with EPCs or their secreted factors could potentiate angiogenesis and neurogenesis after permanent focal cerebral ischemia in a mouse model of ischemic stroke. [...]
2013 - 10.1371/journal.pone.0073244
PloS one, Vol. 8 (september 2013)  
7.
9 p, 4.2 MB Rat Middle Cerebral Artery Occlusion Is Not a Suitable Model for the Study of Stroke-Induced Spontaneous Infections / Campos Martorell, Mireia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Hernandez Guillamon, Maria Mar (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rosell Novel, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gomis Rodríguez, Javier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Salat, David (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; García Bonilla, Lídia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Montaner, Joan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Infections related to stroke-induced immunodepression are an important complication causing a high rate of death in patients. Several experimental studies in mouse stroke models have described this process but it has never been tested in other species such as rats. [...]
2014 - 10.1371/journal.pone.0099169
PloS one, Vol. 9 (june 2014)  
8.
10 p, 1.1 MB Circulating TIMP-1 is associated with hematoma volume in patients with spontaneous intracranial hemorrhage / Navarro-Oviedo, Manuel (Universidad de Navarra) ; Muñoz-Arrondo, Roberto (Instituto de Investigación Sanitaria de Navarra) ; Zandio, Beatriz (Instituto de Investigación Sanitaria de Navarra) ; Marta-Enguita, Juan (Instituto de Investigación Sanitaria de Navarra) ; Bonaterra-Pastra, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rodríguez, Jose Antonio (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ; Roncal, Carmen (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ; Páramo, Jose A. (Clínica Universidad de Navarra) ; Toledo, Estefania (Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición) ; Montaner, Joan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Hernandez Guillamon, Maria Mar (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Orbe, Josune (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ; Universitat Autònoma de Barcelona
Matrix metalloproteinases (MMPs) are proteolytic zinc-endopeptidases regulated by tissue Inhibitors of matrix metalloproteinases (TIMPs). We evaluated the potential of MMPs and TIMPs as clinical tools for Intracranial Haemorrhage (ICH). [...]
2020 - 10.1038/s41598-020-67250-9
Scientific reports, Vol. 10 (june 2020)  
9.
14 p, 488.9 KB Comparison of plasma lipoprotein composition and function in cerebral amyloid angiopathy and Alzheimer's disease / Bonaterra-Pastra, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Fernández-de-Retana, Sofía (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rivas-Urbina, Andrea (Institut d'Investigació Biomèdica Sant Pau) ; Puig Grifol, Núria (Institut d'Investigació Biomèdica Sant Pau) ; Benitez, Sonia (Institut d'Investigació Biomèdica Sant Pau) ; Pancorbo, Olalla (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rodriguez-Luna, David (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Pujadas, Francesc (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Freijo, Maria del Mar (Hospital Universitario de Cruces (Barakaldo, País Basc)) ; Tur, Silvia (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Martinez Zabaleta, Maite (Hospital Universitario de Donostia (Sant Sebastià, País Basc)) ; Cardona, Pere-Joan (Hospital Universitari de Bellvitge) ; Vera, Rocío (Hospital Universitario Ramón y Cajal (Madrid)) ; Lebrato-Hernández, Lucia (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Arenillas, Juan F.. (Universidad de Valladolid. Departamento de Medicina) ; Pérez-Sánchez, Soledad (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ; Montaner, Joan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Sanchez-Quesada, Jose Luis (Institut d'Investigació Biomèdica Sant Pau) ; Hernández-Guillamon, Mar (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Cerebral amyloid angiopathy (CAA) refers to beta-amyloid (Aβ) deposition in brain vessels and is clinically the main cause of lobar intracerebral hemorrhage (ICH). Aβ can also accumulate in brain parenchyma forming neuritic plaques in Alzheimer's disease (AD). [...]
2021 - 10.3390/biomedicines9010072
Biomedicines, Vol. 9 Núm. 1 (2021) , p. 72  
10.
10 p, 736.9 KB Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage : a systematic review and meta-analysis of individual patient data / Al-Shahi Salman, Rustam (Centre for Clinical Brain Sciences. University of Edinburgh) ; Frantzias, Joseph (King's College Hospital NHS Foundation Trust) ; Lee, Robert J. (Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK) ; Lyden, Patrick D. (Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA) ; Battey, Thomas W. K. (Massachusetts General Hospital (Boston)) ; Ayres, Alison M. (Massachusetts General Hospital (Boston)) ; Goldstein, Joshua N. (Massachusetts General Hospital (Boston)) ; Mayer, Stephan A. (Department of Neurology, Henry Ford Health System, Detroit, MI, USA) ; Steiner, Thorsten (Heidelberg University Hospital (Alemanya)) ; Wang, Xia (The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia) ; Arima, Hisatomi (The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia) ; Hasegawa, Hitoshi (Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan) ; Oishi, Makoto (Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan) ; Godoy, Daniel A. (Intensive Care Unit, Hospital Interzonal de Agudos "San Juan Bautista", Catamarca, Argentina) ; Masotti, Luca (Internal Medicine, Santa Maria Nuova Hospital, Florence, Italy) ; Dowlatshahi, Dar (Department of Medicine (Neurology), University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada) ; Rodriguez-Luna, David (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Molina, Carlos A. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Jang, Dong-Kyu (Department of Neurosurgery, Incheon St Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea) ; Dávalos, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Castillo, José (Complejo Hospitalario Universitario de Santiago de Compostela) ; Yao, Xiaoying (Department of Neurology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China) ; Claassen, Jan (Department of Neurology, Columbia University, College of Physicians and Surgeons, New York, NY, USA) ; Volbers, Bastian (Bern University Hospital) ; Kazui, Seiji (Kazui Medical Office, Ikeda, Osaka, Japan) ; Okada, Yasushi (Department of Cerebrovascular Medicine and Neurology, National Hospital Organisation Kyushu Medical Centre, Fukuoka, Japan) ; Fujimoto, Shigeru (Division of Neurology, Department of Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan) ; Toyoda, Kazunori (Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan) ; Li, Qi (Department of Neurology, ThE First Affiliated Hospital of Chongqing Medical University, Chongqing, China) ; Khoury, Jane (University of Cincinnati Medical Centre, Cincinnati, OH, USA) ; Delgado Martínez, María Pilar (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Álvarez Sabín, José (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Hernández-Guillamon, Mar (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Prats-Sánchez, Luis Antonio (Institut d'Investigació Biomèdica Sant Pau) ; Cai, Chunyan (Centre for Clinical and Translational Sciences, McGovern Medical School at the University of Texas Health Science Center, Houston, TX, USA) ; Kate, Mahesh P. (Department of Neurology, University of Alberta, Edmonton, AB, Canada) ; McCourt, Rebecca (Department of Neurology, University of Alberta, Edmonton, AB, Canada) ; Venkatasubramanian, Chitra (Division of Stroke and Neurocritical Care, Stanford University, Palo Alto, CA, USA) ; Diringer, Michael N. (Department of Neurology and Neurological Surgery, Washington University, St Louis, MO, USA) ; Ikeda, Yukio (Department of Neurosurgery, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan) ; Worthmann, Hans (Department of Neurology, Hannover Medical School, Hannover, Germany) ; Ziai, Wendy C. (Johns Hopkins University School of Medicine, Department of Neurology, Anaesthesia and Critical Care Medicine, Division of Neurocritical Care, Baltimore, MD, USA) ; d'Esterre, Christopher D. (Department of Radiology, Foothills Medical Centre, University of Calgary, Calgary, AB, Canada) ; Aviv, Richard I (Department of Medical Imaging, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada) ; Raab, Peter (Institute of Diagnostic and Interventional Neuroradiology, Hannover Medical School, Hannover, Germany) ; Murai, Yasuo (Department of Neurological Surgery, Nippon Medical School, Tokyo, Japan) ; Zazulia, Allyson R. (Department of Neurology and Neurological Surgery, Washington University, St Louis, MO, USA) ; Butcher, Kenneth S. (Department of Neurology, University of Alberta, Edmonton, AB, Canada) ; Seyedsaadat, Seyed Mohammad (Department of Radiology, Mayo Clinic, Rochester, MN, USA) ; Grotta, James C. (Memorial Hermann Hospital (Houston, Estats Units d'Amèrica)) ; Martí-Fàbregas, Joan (Institut d'Investigació Biomèdica Sant Pau) ; Montaner, Joan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Broderick, Joseph P (University of Cincinnati Medical Centre, Cincinnati, OH, USA) ; Yamamoto, Haruko (Center for Advanced Clinical and Translational Sciences, National Cerebral and Cerebrovascular Center, Suita, Osaka, Japan) ; Staykov, Dimitre (Department of Neurology, Hospital of the Brothers of St John, Eisenstadt, Austria) ; Connolly, E. Sander (Department of Neurosurgery, Columbia University, College of Physicians and Surgeons, New York, NY, USA) ; Selim, Magdy (Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA) ; Leira, Rogelio (Complejo Hospitalario Universitario de Santiago de Compostela) ; Moon, Byung Hoo (Department of Neurosurgery, Incheon St Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea) ; Demchuk, Andrew (Department of Clinical Neurosciences and Department of Radiology, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada) ; Di Napoli, Mario (Neurological Service, San Camillo de'Lellis General Hospital, Rieti, Italy) ; Fujii, Yukihiko (Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan) ; Anderson, Craig S.. (The George Institute for Global Health, China at Peking University Health Science Center, Beijing, China) ; Rosand, Jonathan (Massachusetts General Hospital (Boston)) ; Universitat Autònoma de Barcelona
Intracerebral haemorrhage growth is associated with poor clinical outcome and is a therapeutic target for improving outcome. We aimed to determine the absolute risk and predictors of intracerebral haemorrhage growth, develop and validate prediction models, and evaluate the added value of CT angiography. [...]
2018 - 10.1016/S1474-4422(18)30253-9
The Lancet neurology, Vol. 17 (october 2018) , p. 885-894  

Articles : 18 records found   1 - 10next  jump to record:
Research literature 9 records found  
1.
3.8 MB Estudi del metabolisme lipídic perifèric i de l'apolipoproteïna J en l'angiopatia amiloide cerebral / Bonaterra-Pastra, Anna ; Hernández Guillamon, Mar, dir. ; Montaner Villalonga, Juan Bernardo, dir.
La β-amiloïdosi cerebral consisteix en el dipòsit de β-amiloide (Aβ) al cervell, acumulant-se al parènquima en la malaltia d'Alzheimer (MA) o als vasos sanguinis en l'angiopatia amiloide cerebral (AAC). [...]
La β-amilodosis cerebral consiste en el depósito de β-amiloide (Aβ) en el cerebro, acumulándose en el parénquima en la enfermedad de Alzheimer (EA) o en los vasos sanguíneos en la angiopatía amiloide cerebral (AAC). [...]
Cerebral β-amyloidosis is characterized by the deposition of amyloid β (Aβ) in the brain, in parenchyma in Alzheimer's Disese (AD) or in blood vessels in cerebral amyloid angiopathy (CAA). CAA is the main cause of lobar intracerebral hemorrhage (ICH) in the elderly. [...]

2023  
2.
212 p, 5.4 MB Búsqueda de nuevos biomarcadores en la Angiopatía Amiloide Cerebral / Marazuela, Paula ; Hernández Guillamon, Mar, dir. ; Montaner Villalonga, Juan Bernardo, dir.
La β-amiloidosis cerebral es caracteritza per l'acumulació anòmala del pèptid beta amiloide (Aß) en el parènquima i en la paret dels vasos cerebrals, constituint una de les principals característiques neuropatològiques de la Malaltia d'Alzheimer (MA) i de l'angiopatia amiloide cerebral (AAC). [...]
La β-amiloidosis cerebral se caracteriza por la acumulación anómala del péptido beta amiloide (Aβ) en el parénquima y en la pared de los vasos cerebrales, constituyendo una de las principales características neuropatológicas de la Enfermedad de Alzheimer (EA) y de la Angiopatía Amiloide Cerebral (AAC), respectivamente. [...]
Cerebral β-amyloidosis is characterized by parenchymal and vascular deposition of amyloid beta-peptide (Aβ), which are major features of Alzheimer's disease (AD) and Cerebral Amyloid Angiopathy (CAA), respectively. [...]

2021  
3.
200 p, 9.0 MB Estudio patológico de biomarcadores en la Angiopatía Amiloide Cerebral y la Enfermedad de Alzheimer / Camacho Soriano, Jessica ; Martínez Sáez, Elena Antima, dir. ; Hernández Guillamon, Mar, dir. ; Ramón y Cajal Agüeras, Santiago, dir.
Introducció: Nombrosos estudis suggereixen que el deteriorament cognitiu en el cervell ancià típicament presenta un solapament entre patologies neurodegeneratives i vasculars. La malaltia neurodegenerativa més freqüent seria la malaltia d'Alzheimer (MA) i entre les etiologies vasculars més freqüents es troba l'angiopatia amiloide cerebral (AAC). [...]
Introducción: Numerosos estudios sugieren que el deterioro cognitivo en el cerebro anciano típicamente presenta un solapamiento entre patologías neurodegenerativas y vasculares. La enfermedad neurodegenerativa más frecuente sería la enfermedad de Alzheimer (EA) y entre las etiologías vasculares más frecuentes se encuentra la angiopatía amiloide cerebral (AAC). [...]
Introduction: Numerous studies suggest that cognitive impairment in the elderly brain typically presents an overlap between neurodegenerative and vascular pathologies. The most common neurodegenerative disease would be Alzheimer's disease (AD) and among the most common vascular etiologies would be cerebral amyloid angiopathy (CAA). [...]

2021  
4.
212 p, 10.7 MB Estudio de variantes estructurales de ApoA-I y ApoJ recombinantes como aproximación terapéutica en el contexto de la β-amiloidosis cerebral / Fernández-de-Retana, Sofía ; Hernández Guillamón, María del Mar, dir. ; Cano-Sarabia, Mary, dir. ; Montaner, Joan, dir. ; Universitat Autònoma de Barcelona. Institut de Neurociències
La β-amiloidosis cerebral se caracteriza por la acumulación del péptido β-amiloide (Aβ) en el parénquima y vasos cerebrales siendo la principal característica neuropatológica de la Enfermedad de Alzheimer (EA) y la Angiopatía Amiloide Cerebral (18C). [...]
Cerebral β-amyloidosis is characterized by parenchymal and vascular deposition of Amyloid-β peptide (Aβ), being the main neuropathological hallmark of Alzheimer's Disease and Cerebral Amyloid Angiopathy (CAA). [...]

[Bellaterra] : Universitat Autònoma de Barcelona, 2018.  
5.
200 p, 5.7 MB Identificación de biomarcadores en el ictus hemorrágico y su estudio funcional en modelos experimentales / Merino Zamorano, Cristina ; Rodríguez Álvarez, José (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Hernández Guillamón, María del Mar, dir. ; Montaner, Joan, dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
La hemorragia intracerebral (HIC) se define como la extravasación de sangre al parénquima encefálico. Aunque la HIC presenta una elevada tasa de mortalidad y discapacidad, muchos de los mecanismos moleculares implicados en esta patología aún se desconocen. [...]
Intracerebral hemorrhage (ICH) is a focal bleeding from a blood vessel in the brain parenchyma. Despite the high ratio of ICH severity and mortality, the molecular mechanisms involved in this disease are still unknown. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2016  
6.
152 p, 4.4 MB Aplicaciones proteómicas para el descubrimiento de biomarcadores diagnósticos en ictus / Llombart Sebastià, Víctor ; Montaner, Joan, dir. ; Hernández Guillamón, María del Mar, dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
El ictus representa uno de los trastornos neurológicos más severos. En nuestro entorno, esta patología cerebrovascular revela una elevada prevalencia y se sitúa como segunda causa de muerte y primera causa de invalidez y discapacidad, lo que se traduce en un extraordinario impacto a nivel económico, sanitario y social. [...]
Stroke is one of the most severe neurological disorders. In our society, this cerebrovascular disease reveals a high prevalence and represents the second cause of dead and the first cause of disability, with a dramatic impact at the economic, social and health systems. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2016  
7.
186 p, 5.7 MB Eficàcia i seguretat de la simvastatina administrada en la fase aguda de la isquèmia cerebral experimental / Campos Martorell, Mireia ; Hernández Guillamon, Mar, dir. ; Montaner, Joan, dir. ; García-Dorado, David ; Universitat Autònoma de Barcelona. Departament de Medicina
Malgrat tots els esforços realitzats, la realitat és que l'ictus continua sent una de les principals causes de mortalitat i d'incapacitat arreu del món. Actualment, l'únic tractament aprovat per la FDA en la fase aguda de l'ictus isquèmic és el trombolític rt-PA, que tot i haver quedat àmpliament demostrada la seva eficàcia, també se li atribueixen una sèrie d'inconvenients tals com la impossibilitat d'administrar-lo més enllà de les 4. [...]
Despite all the past clinical efforts , stroke remains a major cause of death and disability worldwide. Currently, the only treatment approved by the FDA during the acute phase of ischemic stroke is the thrombolytic rt-PA, which despite its great effectiveness has been widely demostrated, it has also a number of drawbacks such as the impossibility of administrating it beyond 4. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2015  
8.
46 p, 4.8 MB Efectes de l'administració de tpa combinat amb dipyridamole sobre cèl·lules endotelials cerebrals humanes sotmeses a deprivació d'oxigen i glucosa / Parés Oliva, Mireia ; Hernandez Guillamon, Maria Mar ; Montaner, Joan ; Universitat Autònoma de Barcelona. Departament de Medicina ; Universitat Autònoma de Barcelona. Facultat de Medicina
El DP és un agent usat de forma comú en la prevenció secundària de l'ictus per les seves propietats antiplaquetars. Ha estat proposat com a possible teràpia coadjuvant del tractament trombolític en fase aguda de l'ictus isquèmic amb rtPA neuroprotector per les seves propietats neuroprotectores, antiinflamatòries i antioxidants. [...]
2012  
9.
161 p, 1.9 MB Contribució de l'amino oxidasa sensible semicarbazida en el dany vascular : implicació en la malaltia d'Alzheimer i l'angiopatia cerebral amiloide / Hernández Guillamón, María del Mar ; Unzeta López, Mercedes, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular)
L'objectiu principal de la present tesis doctoral ha estat l'estudi de la possible contribució de l'Amino Oxidasa Sensible a Semicarbazida (SSAO) en el dany vascular, la seva implicació en l'Angiopatia Cerebral Amiloide (CAA) i la Malaltia d'Alzheimer (AD). [...]
Bellaterra : Universitat Autònoma de Barcelona, 2006
2 documents

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.